Short-term stake in Nyxoah SA (NASDAQ:NYXH) increases by 107.1%


Nyxoah SA (NASDAQ:NYXH – Get Rating) saw strong growth in short-term interest in April. As of April 30, there were short interests totaling 2,900 shares, a growth of 107.1% from the total of 1,400 shares as of April 15. Based on an average daily trading volume of 2,300 shares, the days-to-cover ratio is currently 1.3 days. Currently, 0.0% of the company’s shares are sold short.

Institutional investors and hedge funds have recently increased or reduced their stakes in the stock. Pura Vida Investments LLC acquired a new stake in Nyxoah during Q3 valued at $6,542,000. Deerfield Management Company LP Series C acquired a new position in Nyxoah during Q3 worth $8,797,000. Putnam Investments LLC purchased a new stake in Nyxoah in Q3 valued at approximately $5,646,000. BlackRock Inc. purchased a new stake in Nyxoah in Q3 valued at approximately $19,612,000. Finally, Credit Suisse AG bought a new stake in Nyxoah in Q3 valued at around $221,000. 10.76% of the shares are held by institutional investors and hedge funds.

A number of analysts have recently released reports on NYXH stocks. Piper Sandler lowered its target price on Nyxoah from $40.00 to $30.00 in a Friday, March 25 report. Zacks Investment Research downgraded Nyxoah shares from a “buy” rating to a “hold” rating in a Friday, April 1 research report. Wolfe Research launched coverage on Nyxoah shares in a research report on Tuesday, April 5. They issued a “market performance” rating and a price target of $21.00 for the company. Finally, Oppenheimer launched a hedge on Nyxoah shares in a research report on Wednesday, April 20. They issued an “outperform” rating and a price target of $30.00 for the company. Two equity research analysts gave the stock a hold rating and five gave the company a buy rating. According to data from MarketBeat.com, the company currently has a consensus rating of “Buy” and a consensus price target of $31.33.

NYXH fell $1.03 during Friday trading hours, hitting $13.10. 8,545 shares of the stock traded in hands, compared to its average volume of 3,300. The company’s fifty-day simple moving average is $17.82 and its two-hundred-day simple moving average is 20, $01. Nyxoah has a fifty-two week low of $12.81 and a fifty-two week high of $37.00. The company has a debt ratio of 0.07, a current ratio of 10.41 and a quick ratio of 12.07.

Nyxoah Company Profile (Get a rating)

Nyxoah SA, a medical technology company, is focused on developing and commercializing solutions to treat sleep-disordered breathing. It offers the Genio System, a hypoglossal, patient-centered, CE-marked neurostimulation therapy to treat moderate to severe obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.

Recommended Stories



Get news and reviews for Nyxoah Daily – Enter your email address below to receive a concise daily summary of breaking news and analyst ratings for Nyxoah and related companies with MarketBeat.com’s free daily email newsletter.

Comments are closed.